March 21, 2016 — Circle Cardiovascular Inc., developer of cardiac magnetic resonance (MR) and computed tomography (CT) post-processing software, unveiled a global multi-year licensing and distribution agreement with GE Healthcare for Circle’s U.S. Food and Drug Administration (FDA)-cleared cmr42 cardiac MR software.
The cmr42 cardiovascular post-processing software package contains a set of comprehensive, easy-to-use modules for viewing and analyzing cardiac MR images for both standalone and enterprise server configurations. Over 600 sites in 35 countries are already interpreting hundreds of thousands of cardiac exams annually using Circle’s cmr42 software to increase diagnostic speed and accuracy, reduce cost and improve patient care. The signing of this collaborative agreement expands the technology reach of Circle’s cmr42 software by way of GE Healthcare offering the product through their global MR sales channels.
For more information: www.gehealthcare.com, www.circlecvi.com
February 21, 2024 
